Heiko Bruhn to Attend the 19th Annual European Life Sciences CEO Forum (Sachs ELSF)
Read more “GenSearch at the European Life Sciences CEO Forum 2026”
Heiko Bruhn to Attend the 19th Annual European Life Sciences CEO Forum (Sachs ELSF)
Read more “GenSearch at the European Life Sciences CEO Forum 2026”
Read more “GenSearch to Attend the Presentation of the Panorama France HealthTech 2026”
Swiss Biotech Day has become one of the most relevant annual events in the European biotechnology calendar. It gathers experts from biotech, pharma, finance, and academia. The 2026 edition will continue to foster international collaboration and exchange across the life sciences industry. We’re also pleased to share that Heiko Bruhn will be attending Swiss Biotech Day 2026. He will contribute to conversations around strategic innovation and international engagement.
Read more “Swiss Biotech Day 2026: Connecting Global Life Sciences Leaders”
To close out 2025, we had the pleasure of welcoming Dominique Pon, CEO of La Poste Santé & Autonomie, for the final HealthTech Dinner of the year in Paris.
At GenSearch, we were proud to co-host the recent HealthTech Dinner in Basel alongside PwC Switzerland. This invitation-only event brought together senior leaders from across the pharma, biotech, and life sciences sectors. The aim was to explore how the industry is transitioning from product-led models to patient- and consumer-centric ecosystems.
Read more “𝗙𝗿𝗼𝗺 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗽𝗲𝗼𝗽𝗹𝗲 – 𝗿𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝗕𝗮𝘀𝗲𝗹”
Heiko Bruhn will be attending this year’s BioAlps Networking Day, held on 11 November 2025 in Monthey, Valais Switzerland
Sebastien Stoitzner and Pauline Rambaud will attend the HealthTech Innovation Days (HTID) taking place on 7-8 October 2025 in Paris, France.

In this session, our expert speakers shared insights into the realities of leadership in private equity-backed companies, what demands, what often goes unsaid, and how to thrive in this high-performance environment.
Read more “Unlocking Private Equity: What It Really Takes to Lead in a PE-Backed Company”